Loading
Gland Pharma Limited Stock: price and insider trades · India
Insider Decl.
474
Thresholds
n/a
Buy Volume
€46,432
2 ops. · all time
Sell Volume
€232M
396 ops. · all time
Who traded when
BuySaleA. Jayatheertha4 sales
Jayatheerth Advani4 sales
P Lakshmi Narayana2 sales
Sreenivasa Rao Suragam2 sales
K Raghuramachandra Rao1 sale
Mirae Asset Mutual Fund1 sale
Analyst consensus: bullish or bearish?
Analysts rate Gland Pharma Limited Buy (bullish), based on 14 analysts. Average price target: ₹2,964.36.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,815 of 26,290 companies
57.8
score / 100
Value36
Quality80
FCF yld1.2%
Earn yld2.2%
EV/EBITDA24.5x
ROE11%
Gross mgn65%
Net mgn16%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹3,019.80
Analyst consensus
14 analystsBuy
₹1,940.00Target ₹2,964.36(-2%)₹3,750.00
Income statement
Revenue₹64B
Gross profit₹41.6B65% margin
EBITDA₹19.2B30% margin
Net income₹10.3B16.8% margin
Valuation
PER (trailing)43.8x
PER (forward)31.3x
P/Book4.8x
Beta0.58
Balance sheet & cash
Market cap₹498.3B
Total debt₹2.8B
Free Cash Flow₹5.4B
Debt / Equity3%
Profitability & ownership
ROE10.5%
ROA6.3%
% insiders51.8%
% institutions37.9%
Last declaration on 3 August 2026
Declarations474 total
300,972 shares-MarketSEBI:aae3c16bc3f9f94f4f3d530203cf8461eb5478be
1,000 shares@ ₹2,355.0036.0% of flowEquity SharesMarket SaleSEBI:b4442f01f2a8438e68a4039a155a5c4ebf4c10c2
1,000 shares@ ₹2,345.90100.0% of flowEquity SharesMarket SaleSEBI:a7d3cb1c9a2a873febf09c8145479c324b5e74b7
500 shares@ ₹2,355.0018.1% of flowEquity SharesMarket SaleSEBI:d13ae7cf1f7ed0dafb0af88fa216a75326196a23
500 shares@ ₹2,300.0034.8% of flowEquity SharesMarket SaleSEBI:56b5338eebd2675facf657485f382f2b6510edb3
346 shares@ ₹2,238.0011.8% of flowEquity SharesMarket SaleSEBI:68dca120f6d903a3f16c9104437cc46422c291ae
1,000 shares@ ₹2,235.0034.1% of flowEquity SharesMarket SaleSEBI:59d197405679181c37c7d69a140c03ea2a5c25ff
1,000 shares@ ₹2,170.0065.2% of flowEquity SharesMarket SaleSEBI:7efbc2210fcb6cecb7353a87ddc530b8eb7336d2
100 shares@ ₹1,888.000.8% of flowEquity SharesSEBI:64359e729f8a302301bcd50e60e0d7e8dc054fa1
306 shares@ ₹1,922.002.4% of flowEquity SharesSEBI:a7470f85ea5c6822c8e9c1f8f1ee31cdca30f082
800 shares@ ₹1,861.004.4% of flowEquity SharesSEBI:9284d4fc50f86c7355e1f6ad615e41666665dda4
300 shares@ ₹1,802.81671.7% of flowEquity SharesSEBI:0c553b126afc4d153b330c6987a647a0162b3bca
191 shares@ ₹1,988.89531.7% of flowEquity SharesSEBI:efc2c4d3c37b3f46d910f3dd4bbb5fc27e56bf0c
325 shares@ ₹2,038.002.8% of flowEquity SharesSEBI:e305c9683f76f7bbfe0369f272f40191c57a5a4d
2,800 shares@ ₹542.002.8% of flowEquity SharesSEBI:7219b733f3d9d15f3f9020dbc6a9bb12c9ff8b1e
1,400 shares@ ₹1,807.85715.8% of flowEquity SharesSEBI:e4ea85dcb0fbf1867d673db8b6c041386654c0fb
5,792 shares@ ₹1,788.77219.3% of flowEquity SharesSEBI:05fbfdc56e93e783b07fc37fd92ccc9856377084
1,950 shares@ ₹1,810.0010.1% of flowEquity SharesSEBI:7bc39ca3abd0d376443a649a5493d36dee74d5d6
1,950 shares@ ₹1,812.286.7% of flowEquity SharesSEBI:f0701641538c4b901e0b3a0d1fe4eb2e3ab8f5aa
6,182 shares@ ₹1,820.253810.1% of flowEquity SharesSEBI:f5df3c409187d16ba48415623ef990eb2e880bdf
2,000 shares@ ₹1,824.9210.5% of flowEquity SharesSEBI:8f689a3055a3a2f0dd127b874064687d16ce52f3
968 shares@ ₹1,825.008.9% of flowEquity SharesSEBI:360d722842482602528dacf731d13346b3e39d4e
1,000 shares@ ₹1,822.003.4% of flowEquity SharesSEBI:225d8f1f09305affbbab911ef21fc9afb4ad2b81
4,000 shares@ ₹1,825.0020.9% of flowEquity SharesSEBI:a10a415c9823cb6c91b3f02c9247f4863b964dfe
2,250 shares@ ₹1,822.444956.2% of flowEquity SharesSEBI:fca8aec1909c14d829cd7cd4f7382df7f7ad6e0c
25 of 474 declarations
About Gland Pharma Limited
On June 19, 2024, Fosun Pharma Industrial Pte. Ltd reported a sale of EUR 195,423,715 at Gland Pharma Limited, most of the EUR 231.9 million sold across the whole record. The other large sales are far smaller: EUR 2,652,595 for Srinivas Sadu on June 9, 2022 and EUR 1,359,498 for Srinivasa Sadu on July 29, 2021.
For the rest, the record is a long run of small sales: 396 in all, with a median of EUR 36,826, against only 2 purchases, EUR 37,661 for A Renuka Devi on May 28, 2021 and EUR 8,771 for P Jitender Reddy on December 20, 2021. A Renuka Devi is the top filer, with 22 filings, 20 of them sales; S Srinivasa Rao has 20, of which 18 sales. Another 76 filings are grants.
Read moreShow less
The pace is concentrated in time: 216 filings in 2021 and 180 in 2022, then 28 in 2023, 35 in 2024, 4 in 2025 and 11 in 2026. The last twelve months hold 12 filings, all sales. An Indian health care and pharma company listed in Bombay, with a market capitalisation of INR 498.3 billion, in which insiders hold 51.8% of the capital. Filings are published a median of 1 day after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
